CSPC - growth potential.Hi everyone.
This is my first idea in English, I decided that it would be more convenient and would reach a large audience.
Briefly for the English-speaking audience: I publish mid-term ideas with an average term of 2-3 months. Over the past month, 3 out of 8 ideas were successfully implemented,
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.0495 EUR
583.29 M EUR
3.91 B EUR
7.85 B
About CSPC PHARMACEUTICAL GROUP LIMITED
Sector
Industry
CEO
Cui Long Zhang
Website
Headquarters
Shijiazhuang
Founded
1994
ISIN
HK1093012172
FIGI
BBG000C1ZYZ2
CSPC Pharmaceutical Group Ltd. is an investment holding company, which is engaged in the manufacturing and selling of pharmaceutical products. It operates through the following business segments: Finished Drugs, Antibiotics, Vitamin C, Caffeine and Others. The company was founded on August 21, 1997 and is headquartered in Shijiazhuang, China.
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange CSPC PHARMACEUT.GR. stocks are traded under the ticker CVG.
We've gathered analysts' opinions on CSPC PHARMACEUT.GR. future price: according to them, CVG price has a max estimate of 1.52 EUR and a min estimate of 0.55 EUR. Watch CVG chart and read a more detailed CSPC PHARMACEUT.GR. stock forecast: see what analysts think of CSPC PHARMACEUT.GR. and suggest that you do with its stocks.
Yes, you can track CSPC PHARMACEUT.GR. financials in yearly and quarterly reports right on TradingView.
CSPC PHARMACEUT.GR. is going to release the next earnings report on Aug 20, 2025. Keep track of upcoming events with our Earnings Calendar.
CVG net income for the last half-year is 176.33 M EUR, while the previous report showed 391.21 M EUR of net income which accounts for −54.93% change. Track more CSPC PHARMACEUT.GR. financial stats to get the full picture.
CSPC PHARMACEUT.GR. dividend yield was 5.44% in 2024, and payout ratio reached 65.03%. The year before the numbers were 3.86% and 51.22% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Jun 14, 2025, the company has 21.4 K employees. See our rating of the largest employees — is CSPC PHARMACEUT.GR. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CSPC PHARMACEUT.GR. EBITDA is 901.38 M EUR, and current EBITDA margin is 23.06%. See more stats in CSPC PHARMACEUT.GR. financial statements.
Like other stocks, CVG shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CSPC PHARMACEUT.GR. stock right from TradingView charts — choose your broker and connect to your account.